On the basis of the current data published for 2013, more than 34 800 patients are now treated annually in Europe with hematopoietic stem cell transplantation (HSCT), 1 which is an increase of 50% over the last 10 years. 2 Reports from the European Blood and Marrow Transplantation Group and the Centre for International Blood and Marrow Transplant Registry have illustrated that transplant rates differed substantially between countries. 3 They have shown that, in part, the differences in transplant activity among European countries and worldwide are based on economic grounds. Transplant rates were higher in countries with higher gross national income or health-care expenditures per capita. [4] [5] [6] [7] The positive relationship between transplant rates, team density and access to the therapeutic procedure have also been discussed. [5] [6] [7] [8] There is a wide range of health-care organizational systems in Europe with important economic differences among them that could explain some of the differences between HSCT rates in European countries at the macro level. [4] [5] [6] [7] However, it has not been investigated whether economic factors may also explain part of rates differences in HSCT found between regions of a particular country. This micro level scenario generally involves one organizational health-care system and economics and clinical differences should not be expected to cause different transplant rates between the regions in a country.
The objective of this study is to identify and estimate the economic determinants, which might explain the differences in HSCT activity between autonomous regions in Spain. In Spain, hematopoietic transplant coverage is universal and free under the National Health System, but each regional government can autonomously decide on local health policies and determine which services/types of transplantation to provide out of a portfolio of basic services (decentralization). It is a fact that HSCT rates greatly differ among the 17 Spanish autonomous regions.
This study was carried out in 2010, 2011 and 2012. The total number of stem cell transplantations (autologous and allogeneic) performed in each region and the number of transplants teams were obtained and validated by two independent sources: Spanish National Transplant Organization [9] [10] [11] and Spanish Group of Transplant and Cellular Therapy (GETH). Economic information, such as gross domestic product (GDP) and population per autonomous region, was obtained from the Spanish National Institute of Statistics.
12,13 Data on public health-care expenditure (HCE) and public hospital health-care expenditure (HHCE) per autonomous region were obtained from the Spanish Ministry of Health.
14 Definitions of variables. Transplant rate (dependent variable) was defined as the number of transplants for a given region in comparison with its population, with adjustments to 1 million inhabitants. Team density was the number of transplant teams per autonomous region per 1 million inhabitants per year. As macroeconomic factors, GDP per capita was defined as the division of GDP of a given region by its population per year and squared GDP was introduced to control the non-linear relationship between GDP and transplant rate; public HCE per capita and public HHCE per capita were obtained by dividing public HCE and HHCE for each region by its population for each year; and HHCE by health-care expenditure was designed as the public HHCE of a given region by its HCE for each year.
Descriptive analyses of all variables and multiple linear regression studies based on panel data models were estimated to determine the influence of economic factors and team density on the HSCT rate per region. 15 Particularly, given that there was auto-correlation between the number of transplants in each year in relation to the number of transplants the year before in each region; and correlation between the number of transplants in each region and the rest of the Spanish's regions in a specific year, the appropriate model to estimate was the contemporary regression model to panel data. Specifically, six panel data models were performed according to the dependent and independent variables. Regarding the variable to be explained, 'Total', 'Autologous' and 'Allogeneic' models took into account the total, autologous and allogeneic transplant rates as dependent variables. In terms of the independent variables, two sub-models were identified to obtain detailed information: sub-model 'A' quantified GDP, GDP All 17 Spanish autonomous regions were included in the analyses. The mean transplant rate was 60 HSCT per million inhabitants in the period 2010-2012, of which~38 per million were autologous and 22 per million were allogeneic. There were marked differences in transplant rates between regions, ranging from 6.86 to 162.32 per million inhabitants (Supplementary Table 1 ; Supplementary Figure 1) . Supplementary Table 1 also reflects the descriptive analysis of the economic variables.
All the models were fit well (global significance P-value = 0.0000). GDP per capita, public HCE and HHCE per capita and team density showed a significant impact on the total HSCT activity in Spain, as shown in Table 1 (Total A). In particular, an increase of €1000 in GDP per capita would cause an average increase of 1.40 transplants per million inhabitants. Non-linear function of the GDP per capita (shown by the significance of GDP 2 parameter) indicated that a growth occurs in the rate of transplants up to a maximum of €25 710 GDP per capita, from which, the transplant rate tends to stabilize with a slight decline. Likewise, higher public HCE per capita (β = − 62.119; P-value = 0.000) was strongly related to fewer transplant activity. This result is opposite to those found by other authors when comparing between countries. 4, [5] [6] [7] This may be due to the demographic heterogeneity (number of inhabitants) among regions in Spain. The autonomous communities with smaller populations are those which possess a greater HCE per capita as they have to make a greater effort in health expenditure per capita to ensure that the basic health care to their residents is the same than the residents of other regions and support the same fixed costs. However, this economic effort could not be enough to implement certain specialized health-care services such as the HSCT characterized by a high complexity and associated cost. On the other hand, the HHCE was positively associated with the transplantation activity. An increase in €1000 in HHCE in any region would translate into an increase of 89.330 transplants more per million inhabitants. (β = 89.330; P-value = 0.041). This result was doubly contrasted in the Total B model where it was determined that an increase of 1% in HHCE with respect to HCE caused an increase in the number of transplantations of 1.302 per million inhabitants (β = 1.302; P-value = 0.013). The root cause lies in the high cost associated with infrastructure, equipment, specialized staff and suitable technology needed to perform hematopoietic transplant. This means that each region has to increase the hospital expenditure even over that which the HCE increases, meaning that a big budgetary 'effort' is necessary at the expense of the rest of public health services. An increase of one extra unit of transplant centers by each region would suppose 5.556 additional transplants per million inhabitants per year (β = 5.556; P-value = 0.018).
Different results were obtained by type of transplant (Table 2 ). Although team density was the only positive significant variable associated with autologous transplant activity (Autologous A and B) (β = 7.097; P-value = 0.000/β = 6.538; P-value = 0.000), most macroeconomic variables were found to be strongly related with allogeneic transplant activity (Allogeneic A and B). Interestingly, GDP and HHCE per capita influenced allogeneic transplant rate positively, that is, €1000 more in GDP per capita meant an increase in allogeneic transplant rate of 0.94 and 72.45 additional allogeneic transplants respectively per million inhabitants. However, HCE per capita was again negatively associated with HSCT rate (β = − 58.962; P-value = 0.000) (Allogeneic A). In addition, the Allogeneic B model complemented the results in the Allogeneic A model and identified HHCE by health-care expenditure as a positive significant determinant of allogeneic transplant activity (β = 1.006; P-value = 0.001). Team density was not a relevant factor for allogeneic transplantation activity.
Our results are in line with those observed at the European and worldwide levels [5] [6] [7] showing that the macroeconomic variables determine part of the differences in the activity of HSCT among countries. Our findings strongly suggest that causes and similar consequences can also occur between the regions of a decentralized decision-making country, but under the protection of a same scenario of health rights. In contrast to Gratwhol et al, [4] [5] [6] [7] we differentiated between types of transplants and estimated a complex statistical model of panel data that underpins our results. The results obtained show that autologous transplantation rate is only associated with team density, whereas there is a strong influence of macroeconomic determinants in the case of allogeneic transplant rate.
Therefore, a possible inequality in access to the different types of haematopoietic transplants by region based on per capita income, team density and in public hospital expenditure effort has Abbreviations: GDP = gross domestic product; HCE = public health-care expenditure; HHCE = public hospital health-care expenditure; HSCT = hematopoietic stem cell transplantation. Significance level at *90%, **95%, ***99%. S.e.m. in brackets. Independent variables of 'Autologous A' and 'Allogeneic A' models: GDP, GDP 2 , HCE, HHCE and team density. Independent variables of 'Autologous B' and 'Allogeneic B' models: GDP, GDP 2 , HHCE by HCE and team density. Note, the difference between model A and B is that in model B the HHCE and HCE have been replaced with its ratio (HHCE/HCE) in order to isolate the effect of the budgetary effort in HHCE regarding the global HCE. The estimated parameters were weighted according to the population size. , HHCE by HCE and team density. Note, the difference between model A and B is that in model B the HHCE and HCE variables have been replaced with its ratio (HHCE/HCE) in order to isolate the effect of the budgetary effort in HHCE regarding the global HCE. The estimated parameters were weighted according to the population size.
been observed in Spain. The causes and consequences of such differences could be the subject of further investigations. Although incidence of hematological transplantable diseases could not be included in the analyses due to lack of systematic national information, it seems that there is no clear pattern of higher incidence in any particular Spanish region. These findings may be useful to health authorities for making decisions both at the macroeconomic and local levels.
